The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Katie Shannon’s story: The colleague behind facility construction
The missing element is personalization
Video
The need for viral vector production is growing quickly, driven by their crucial role in gene therapies. However, there exists a notable gap in commercial manufacturing capabilities. Thermo Fisher is committed to meeting this need, spearheading the establishment of state-of-the-art facilities.
At the forefront of this challenge is Katie Shannon, who’s been instrumental in navigating these construction projects. By collaborating closely with drug developers, Katie ensures that all project timelines are fulfilled, ultimately advancing the delivery of novel gene therapies to patients in need.
Watch Katie’s story to learn about her role at Thermo Fisher, where her signature attire is a professional blazer on top and construction boots on bottom. Together with our partners, she’s tailoring our facilities for viral vector production, accommodating diverse sizes and scales of processes and platforms.